Healthcare


 Imugene Limited Provided Quarterly Cash Flow Report For March Quarter

Imugene Limited Provided Quarterly Cash Flow Report For March Quarter

April 16, 2019 06:17 PM AEST| By Team Kalkine Media

Biotechnology company, Imugene Limited (ASX: IMU) is an emerging leader in cancer immuno-oncology which has made significant progress in the recent past. Today, the company has announced its quarterly cash flow report for the quarter ended 31 March 2...

 HeraMed collaborates with Meerkats for Australian B2C launch

HeraMed collaborates with Meerkats for Australian B2C launch

April 16, 2019 05:18 PM AEST| By Team Kalkine Media

HeraMed Limited (ASX: HMD) is a medical technology company that develops and sells pregnancy monitoring solutions in Australia, Europe, and Israel. On April 16th, 2019, the company announced to have entered into a partnership with Australian creative...

 Starpharma Holdings’ Shares Surged Over 7% On ASX Post First VivaGel BV Launch Announcement

Starpharma Holdings’ Shares Surged Over 7% On ASX Post First VivaGel BV Launch Announcement

April 16, 2019 02:40 PM AEST| By Team Kalkine Media

Starpharma Holdings Limited (ASX: SPL) announced that they have successfully launched VivaGel? BV (an Australian innovation) in Australia through Aspen Pharmacare (Aspen) as Fleurstat BVgel. This is the first launch and distribution of product across...

 Osprey’s Shares Climbed up on ASX As DyeVert First Quarter Unit Sales Grew by 73%  

Osprey’s Shares Climbed up on ASX As DyeVert First Quarter Unit Sales Grew by 73%  

April 16, 2019 02:21 PM AEST| By Team Kalkine Media

Osprey Medical Inc. (ASX: OSP) has a mission to improve outcomes in chronic kidney disease patients by reducing contrast-induced acute kidney injury and lowering hospital costs. It is a commercial stage company under the health care sector. The comp...

 Paradigm Announces Launch Of A$77.9 Mn Capital Raise For Clinical Trials

Paradigm Announces Launch Of A$77.9 Mn Capital Raise For Clinical Trials

April 15, 2019 10:40 PM AEST| By Team Kalkine Media

Paradigm Biopharmaceuticals Limited (ASX: PAR) announced launch of A$77.9 million capital raise anticipated to fund the company?s osteoarthritis (OA) and mucopolysaccharidosis (MPS) programs through to the end of their pivotal Phase 3 studies, new dr...

 ResApp Health Submitted De Novo Application to the FDA For ResAppDx-US

ResApp Health Submitted De Novo Application to the FDA For ResAppDx-US

April 15, 2019 03:02 PM AEST| By Team Kalkine Media

A leading digital health company, ResApp Health Limited (ASX: RAP) has submitted an application to the US Food and Drug Administration (FDA) for De Novo classification of ResAppDx-US.? ResAppDx-US is a mobile software application used by clinicians a...

 Organic Food major Wattle Health Australia issues an update on Blend & Pack Acquisition

Organic Food major Wattle Health Australia issues an update on Blend & Pack Acquisition

April 15, 2019 02:55 PM AEST| By Team Kalkine Media

Wattle Health Australia Limited (ASX: WHA) is on the journey to becoming known for offering sustainable, organic products of superior quality targeting people across all age groups. Wattle Health uses natural ingredients with a focus on preserving nu...

 A look at the healthcare stock: ASX: NAN

A look at the healthcare stock: ASX: NAN

April 14, 2019 10:15 AM AEST| By Team Kalkine Media

Nanosonics Limited (ASX: NAN), established in 2000 and based out of Lane Cove in Australia, is engaged in designing and developing decontamination products to minimise the spread of infection. The company holds intellectual property rights over a spe...

 Are These Two Small Cap Healthcare Stocks Too Hot To Punt On - PGC, IDX?

Are These Two Small Cap Healthcare Stocks Too Hot To Punt On - PGC, IDX?

April 14, 2019 09:15 AM AEST| By Team Kalkine Media

Paragon Care Limited Paragon Care Limited (ASX: PGC) caters to the Australian and New Zealand medical equipment devices and consumables market. The ageing demographics, constant upgradation in consumer expectations and coupled with resilient governm...

 MGC Pharmaceuticals Grabs CannEpilTM Import Permit For UK With First Formal Purchase Orders

MGC Pharmaceuticals Grabs CannEpilTM Import Permit For UK With First Formal Purchase Orders

April 12, 2019 02:58 PM AEST| By Team Kalkine Media

MGC Pharmaceuticals Ltd (ASX: MXC), a European based specialist medical cannabis biopharma company, on 12 April 2019 announced that it had received a United Kingdom Controlled Drug Import Licence permit to import CannEpilTM into the United Kingdom. O...

 Audio wearables company, Nuheara launches Direct to Consumer Self Care hearing online platform

Audio wearables company, Nuheara launches Direct to Consumer Self Care hearing online platform

April 12, 2019 02:06 PM AEST| By Team Kalkine Media

Nuheara Limited (ASX: NUH) is a leading audio wearables technology company that develops and provides personal hearing devices based on proprietary and multi-functional intelligent hearing technology that improves a person?s hearing and supports cabl...

 Virtus Health Collaborates With Vitrolife And Harrison. AI For Ivy AI Technology

Virtus Health Collaborates With Vitrolife And Harrison. AI For Ivy AI Technology

April 11, 2019 06:15 PM AEST| By Team Kalkine Media

Virtus Health Limited (ASX: VRT), based in Greenwich, Australia, offers a range of fertility care and related specialised diagnostic and day hospital services in New South Wales, Queensland, Victoria, Tasmania, Denmark, the United Kingdom, Ireland, a...

 Creso Pharma to raise A$5.35 million via a series of secured loans

Creso Pharma to raise A$5.35 million via a series of secured loans

April 11, 2019 05:23 PM AEST| By Team Kalkine Media

Creso Pharma Limited (ASX: CPH) is a pharmaceutical company, working in the medical cannabis sector. It aims to improve the lives of both humans as well as animals. The company strives to make the highest quality products by utilising its expertise a...

 Imagion Received An Order Related To Cancer Treatment From NewPhase; Stock Surged Up By 8%

Imagion Received An Order Related To Cancer Treatment From NewPhase; Stock Surged Up By 8%

April 11, 2019 04:52 PM AEST| By Team Kalkine Media

On 11 April 2019, Imagion Biosystems Limited (ASX: IBX), dedicated to improving healthcare through the earlier detection of cancer, notified the market that NewPhase Ltd., an Israeli biotechnology company developing cancer treatments, has issued an e...

 Immuron To Pursue Clinical Development Through FDA For IMM-124E As TD Drug

Immuron To Pursue Clinical Development Through FDA For IMM-124E As TD Drug

April 11, 2019 04:09 PM AEST| By Team Kalkine Media

Immuron Limited (ASX: IMC) is a biopharmaceutical sector company with operations in Australia. The group is also engaged in the commercialization and development of oral immunoglobulin therapeutics for the treatment of gut mediated diseases. The com...

 Oneview Announced The Successful Conduct Of A $25m Capital Raising And Upcoming EGM

Oneview Announced The Successful Conduct Of A $25m Capital Raising And Upcoming EGM

April 11, 2019 03:38 PM AEST| By Team Kalkine Media

On 11th April 2019, patient engagement software company, Oneview Healthcare PLC (ASX: ONE) notified the market that it has successfully conducted a placement to raise A$25 million through the issue of 100 million new CHESS depository interests over n...

 HeraMED Enters UK through Launch of B2C Website

HeraMED Enters UK through Launch of B2C Website

April 11, 2019 02:35 PM AEST| By Team Kalkine Media

HeraMED Limited (ASX: HMD) is an innovative medical technology company. It is into providing pregnancy monitoring solutions for home and professional use. The company cooperates with expecting parents, offer solutions related to problems associated w...

 A look at upward momentum of newly listed stock- ASX: EOF

A look at upward momentum of newly listed stock- ASX: EOF

April 10, 2019 05:21 PM AEST| By Team Kalkine Media

Ecofibre Limited (ASX: EOF), established in 2009 and based in Queensland, is engaged in the production and commercialisation of hemp products in the United States and Australia. It offers a wide range of products including dehulled hemp seeds, protei...

 Actinogen Medical Envisages New Clinical Development Opportunities For Xanamem

Actinogen Medical Envisages New Clinical Development Opportunities For Xanamem

April 10, 2019 02:06 PM AEST| By Team Kalkine Media

Actinogen Medical Limited (ASX: ACW) operates as a biotechnology company. The Company focuses on the treatment of Alzheimer's disease and mild cognitive impairment. The company, today on 10th April 2019, has updated regarding an expanded clinical de...

 Nanollose Updates On Second Pilot Production Of Nullarbor™ Fibre For Nonwoven Applications

Nanollose Updates On Second Pilot Production Of Nullarbor™ Fibre For Nonwoven Applications

April 09, 2019 07:04 PM AEST| By Team Kalkine Media

Nanollose Limited (ASX: NC6) is an ASX listed research and development company that is aiming to replace conventional plant-derived cellulose fibres by fibres, which are grown by low cost and eco-friendly fermentation process. Cellulose is the hidden...

AU_advertise

Advertise your brand on Kalkine Media

Recent Articles






Investing Tips

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.